News Releases

FARAPULSE Extensively Showcased at Leading AF Symposium

Company’s technology and clinical progress detailed across more than 12 lectures/posters

Read more

FARAPULSE featured prominently at 2019 HRS Scientific Sessions

Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology’s potential to achieve new standard of care in treating Atrial Fibrillation

Read more

FARAPULSE Receives FDA Breakthrough Designation for its Endocardial Pulsed Field Ablation System

Menlo Park, California – May 8, 2019 – FARAPULSE Inc. (“FARAPULSE” or “the “Company”) today announced it has received Breakthrough Device designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) for its Endocardial Ablation System.

Read more